← Back to Search

Procedure

Advanced Cochlear Implant Programming for Hearing Loss (TFS4CIs Trial)

N/A
Recruiting
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measure collected at 4-week midpoint during psychophysical training.
Awards & highlights

TFS4CIs Trial Summary

This trial is testing whether adding back information that cochlear implants discard can improve music and speech perception for users.

Who is the study for?
This trial is for cochlear implant users who want to improve their music and speech perception. It's not open to anyone under the age of 18.Check my eligibility
What is being tested?
The study tests how changing stimulation rates and electrode locations in cochlear implants affects the user's ability to perceive music and speech by including temporal fine structure information.See study design
What are the potential side effects?
Since this trial involves non-pharmaceutical interventions, typical drug side effects are not expected. However, changes in implant settings may cause discomfort or require an adjustment period.

TFS4CIs Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measure collected at 8-week endpoint following psychophysical training.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measure collected at 8-week endpoint following psychophysical training. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Baseline electrode psychophysics prior to training.
Endpoint electrode psychophysics.
Midpoint electrode psychophysics.

TFS4CIs Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Stimulation RateExperimental Treatment2 Interventions
Group II: Electrode LocationActive Control2 Interventions

Find a Location

Who is running the clinical trial?

University of Southern CaliforniaLead Sponsor
905 Previous Clinical Trials
1,596,254 Total Patients Enrolled
7 Trials studying Hearing Loss
1,067 Patients Enrolled for Hearing Loss
University of RochesterOTHER
837 Previous Clinical Trials
518,128 Total Patients Enrolled
2 Trials studying Hearing Loss
326 Patients Enrolled for Hearing Loss
Ohio State UniversityOTHER
829 Previous Clinical Trials
505,719 Total Patients Enrolled
5 Trials studying Hearing Loss
262 Patients Enrolled for Hearing Loss

Media Library

Electrode Location (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04708717 — N/A
Hearing Loss Research Study Groups: Stimulation Rate, Electrode Location
Hearing Loss Clinical Trial 2023: Electrode Location Highlights & Side Effects. Trial Name: NCT04708717 — N/A
Electrode Location (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04708717 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor presently welcoming participants?

"The clinical trial is actively recruiting, as demonstrated by the information featured on clinicaltrials.gov. The research project was first published on September 1st 2020 and has been updated to reflect new developments since October 25th 2022."

Answered by AI

How many subjects have been enrolled in this clinical investigation?

"Affirmative. According to the records hosted on clinicaltrials.gov, this medical research is currently seeking participants for its trial which was first posted in September of 2020 and recently updated in October of 2022. The study needs 24 individuals from a single location to participate."

Answered by AI
~2 spots leftby Sep 2024